The STEP (Semaglutide Treatment Effect in People with Obesity) trials involved thousands of participants and demonstrated significant weight loss results while monitoring safety: Most participants experienced 15-20% weight loss over 68 weeks The safety profile was consistent with other GLP-1 receptor agonists Discontinuation rates due to adverse events were about 7% (compared to 3.1% with placebo) Trial participants maintained regular medical supervision throughout The STEP-1 trial, published in the New England Journal of Medicine, showed that semaglutide produced greater weight loss than any other FDA-approved anti-obesity medication to date, with a safety profile deemed acceptable by medical authorities
Includes 2,000 mg of L-Carnitine L-Tartrate to support the bodys ability to use fat for fuel during intense exercise
Before adding supplements, ensure you are drinking plenty of water and eating a diet rich in sulfur-containing foods like garlic, onions, and cruciferous vegetables (broccoli, kale)
Some providers recommend keeping it in your mouth as long as possible
Q5: Is liquid L-Carnitine better than capsules
In clinical trials, participants who stopped semaglutide regained a significant portion of the weight theyd lost within about a year
.png)
